Iteos Therapeutics Inc's Customers Performance

Name: Iteos Therapeutics Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

ITOS

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


ITOS's Source of Revenues		• List of ITOS Customers

for the same period Iteos Therapeutics Inc

• List of ITOS Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Iteos Therapeutics Inc's Comment on Sales, Marketing and Customers

News about Iteos Therapeutics Inc Contracts

Evaluating the Future of Inupadenant in Oncology Promising Data Amidst Market Challenges

Inupadenant, developed by iTeos Therapeutics, has recently gained attention following its presentation of interim clinical trial data at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress. This intriguing agent, when used in conjunction with carboplatin and pemetrexed, has demonstrated noteworthy efficacy in treating certain cancers. However, the company s recent share performance indicates significant challenges in the market environment, raising questions about its strategic direction and commercial viability. Trial Data Overview The Phase 2 A2A-005 trial examining the efficacy of Inupadenant combined with carboplatin/pemetrexed reported promising results. The overall response rate (...

iTeos Therapeutics' Pioneering Cancer Research: Preclinical Data on Groundbreaking EOS-984 Unveiled in AACR Annual Meeting 2024

iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical trailblazer in the...

ITOS's Stock Performance relative to it's Customers

ITOS's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Iteos Therapeutics Inc	442.18	454.23	-202.41	157
SUBTOTAL	0.00	0.00	0.00	-

Sources: Iteos Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Iteos Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Iteos Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.